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O-GlcNAc Modification Is an Endogenous Inhibitor
of the Proteasome
((1-7) (1-7) (1-7) (1-7)). It has three distinct peptidase activi-
ties: chymotrypsin-like, trypsin-like, and postglutamyl
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University of Alabama at Birmingham Slaughter, 1999). The core particle alone cannot degrade
ubiquitinylated protein substrates. The degradation ofBirmingham, Alabama 35294
4 The Salk Institute for Biological Studies protein substrates requires the 19S regulatory particle
(PA700), which is 900 kDa in size and is composed ofGene Expression Laboratory
La Jolla, California 92037 about 17 subunits. The regulatory particle binds to one
or both ends of the core particle. Besides opening the
core particle channel, perhaps for both entry and exit
(Ko¨hler et al., 2001), the 19S cap recognizes and unfoldsSummary
ubiquitin-conjugated proteins and thereby controls the
access of the substrates into the cavity of the coreThe ubiquitin proteasome system classically selects
its substrates for degradation by tagging them with particle. The hexameric ring that contacts the heptam-
eric  ring of the core particle is composed of six differ-ubiquitin. Here, we describe another means of control-
ling proteasome function in a global manner. The 26S ent ATPases, which belong to the AAA protein family.
Studies with the archaebacterial proteasome demon-proteasome can be inhibited by modification with the
enzyme, O-GlcNAc transferase (OGT). This reversible strate that ubiquitin-conjugated proteins are unfolded
or threaded in a C- to N-direction through the ATPasemodification of the proteasome inhibits the proteolysis
of the transcription factor Sp1 and a hydrophobic pep- ring followed by translocation into the channel of the
core particle (Navon and Goldberg, 2001) where degra-tide through inhibition of the ATPase activity of 26S
proteasomes. The Rpt2 ATPase in the mammalian pro- dation occurs. Evidence from yeast proteasomes sug-
gests that the six ATPases work coordinately and areteasome 19S cap is modified by O-GlcNAc in vitro and
in vivo and as its modification increases, proteasome not functionally redundant (Rubin et al., 1998). Studies
using mutations in the AAA ATPase, Rpt2, have sug-function decreases. This mechanism may couple pro-
teasomes to the general metabolic state of the cell. gested that this ATPase has an opening function for
protein access to the core particle (Ko¨hler et al., 2001;The O-GlcNAc modification of proteasomes may allow
the organism to respond to its metabolic needs by Rubin et al., 1998).
It has been suspected that the UPS is under metaboliccontrolling the availability of amino acids and regula-
tory proteins. control. The digestion of muscle fiber by the proteasome
is stimulated during starvation (Jagoe et al., 2002),
thereby providing the energy stored in amino acids toIntroduction
the animal. The degradation of the transcription factor,
Sp1 has been demonstrated to be both proteasome andThe proteome is in a dynamic state of renewal and this
metabolism must be coordinated with the needs not only glucose dependent (Han and Kudlow, 1997; Su et al.,
1999). Its proteasomal degradation in cultured cells isof the cell, but the metazoan as a whole. The ubiquitin-
proteasome system (UPS) plays a major role in the deg- inhibited by LLnL and lactacystin and by culture in high
glucose or glucosamine (GlcN) (Han and Kudlow, 1997)radation of the intracellular protein (for reviews, see
Glickman and Ciechanover, 2002; Voges et al., 1999; and conversely stimulated by glucose deprivation and
forskolin. Nuclear extract (NE) from glucose-starved/DeMartino and Slaughter, 1999). Not only does it remove
damaged proteins, but it also regulates the concentra- forskolin-treated cells also degrades recombinant Sp1
tion of short-lived proteins such as cyclins and transcrip- (Su et al., 1999). An ATPase mutant of Sug1 (Su et al.,
tion factors like -catenin (Aberle et al., 1997) and p53 2000), one of the six ATPases in the regulatory particle,
(Honda et al., 1997). Hence, the UPS is central to the blocks Sp1 degradation. We have postulated that this
basic mechanisms of cell division, differentiation or coupling of Sp1 proteasomal degradation to metabolic
death. Proteins destined for degradation are usually intermediates is part of a mechanism relating macromo-
tagged with ubiquitin in a temporally and protein-spe- lecular synthesis to substrate availability. Sp1 is modi-
cific manner and then degraded by the proteasome us- fied posttranslationally by the monosaccharide N-ace-
ing ATP. tylglucosamine (GlcNAc) through -linkage to serine or
The proteasome is composed of a cylindrical 20S, 670 threonine hydroxyl groups (Jackson and Tjian, 1988;
kDa core particle and a 19S regulatory particle. The core Roos et al., 1997). O-linked GlcNAc (O-GlcNAc) occurs
particle is composed of 28 subunits,  and  in type, dynamically on many nuclear and cytoplasmic proteins
which are arranged in four stacked heptagonal rings (Comer and Hart, 2000; Wells et al., 2001; Hanover,
2001). Because the degradation of Sp1 could be blocked
by glucosamine, a metabolite in the O-GlcNAc pathway,*Correspondence: kudlow@uab.edu
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this modification pathway became a candidate for this assay also inhibited GST-Sp1 degradation by the active
nuclear portion (Figure 1D, lane 2). These results, takencoupling of the metabolic state to proteasomal function.
The addition of O-GlcNAc to proteins is catalyzed by together, indicate that catalysis by OGT and not the TPR
domain or tag, interferes with the degradation of GST-O-GlcNAc transferase (OGT) (Krepple et al., 1997; Lubas
et al., 1997) and its removal by O-GlcNAc-selective tagged Sp1.
N-acetyl--D-glucosaminidase (O-GlcNAcase) (Gao et
al., 2001). While it is now clearer that OGT plays a role The O-GlcNAc State of Sp1 Has No Effect
in transcriptional regulation (Roos et al., 1997; Yang et on Its Proteolysis
al., 2001, 2002), its role in coupling the proteasome to The activated nuclear extract was pretreated with GST-
metabolism has not been thoroughly investigated. In OGT or His-OGT beads and then these beads were re-
this paper, we show that proteasome functions could moved before the addition of GST-Sp1, suggesting that
be reversibly inhibited by O-GlcNAc modification. The the OGT acted upon the proteasome or some compo-
inhibition of the proteasome in susceptible cells may nent in the nuclear extract, but not on Sp1. Nevertheless,
cause the accumulation of proapoptotic factors re- some of the OGT remained, thereby potentially modi-
sulting in apoptosis much as exogenous proteasome fying Sp1, an O-GlcNAc protein. To control for Sp1 gly-
inhibitors do (Lee and Goldberg, 1998; Qiu et al., 2000; cosylation, the GST-Sp1 was expressed under different
Pasquini et al., 2000; Adams et al., 1999; Hideshima et conditions to generate GST-Sp1 in various states of
al., 2001). The identification of a metabolically coupled O-glycosylation. The level of Sp1 O-glycosylation was
endogenous regulatory pathway for proteasomes inde- measured with RL-2, an anti-O-GlcNAc monoclonal anti-
pendent of the ubiquitin system may provide a means body (Figure 2B). When the Sp1 is expressed in cells
for globally controlling this organelle in conditions such exposed to glucose-free medium, it is only barely de-
as starvation, uncontrolled diabetes, cancer, and inflam- tectable with RL-2 (Figure 2B, lane 1), whereas cells
mation (Goldberg and Rock, 2002; Kisselev and Gold- exposed to glucose, glucosamine, or streptozotocin
berg, 2001). (STZ), a non-competitive inhibitor of O-GlcNAcase (Roos
et al., 1998; Hanover et al., 1999; Yang et al., 2001),
express a similar amount of Sp1 protein that is detect-Results
able with RL-2 (Figure 2B, lanes 2 to 4). Nevertheless,
the degradation of GST-Sp1 and generation of SpX byOGT Inhibits the Proteasomal Dependent
the activated nuclear extract were not significantly af-Degradation of Sp1
fected by the initial state of Sp1 O-glycosylation (FigureNuclear extract from glucose-starved/forskolin-treated
2C). Furthermore, the degradation of the variously glyco-NRK cells (activated extract) can replicate the in vivo
sylated forms of Sp1 could be inhibited equally by the(Han and Kudlow, 1997) degradation of Sp1 (Su et al.,
pretreatment of the nuclear extract with GST-OGT on1999, 2000). The in vivo and in vitro degradation can be
affinity beads (Figure 2D, lanes 1 to 4). The O-glycosyla-blocked by proteasome inhibitors. In vitro degradation
tion state of Sp1 does control its entry into transcrip-of Sp1 occurs as a two-step process (Su et al., 1999)
tional complexes (Roos et al., 1997; Yang et al., 2001,beginning with an endopeptic cleavage between leu56
2002).and leu57 in Sp1 (Su et al., 1999) (Supplemental Figure
S1 available online at http://www.cell.com/cgi/content/
full/115/6/715/DC1). A glycine-rich N-terminal peptide, The Effect of OGT on the Peptidase Activity
of the ProteasomeSpX, is generated while the major downstream portion
of Sp1 is further degraded. While forskolin-activated Inhibition of Sp1 degradation in nuclear extract by OGT
could result from the modification of the proteasomenuclear extract could cleave Sp1 (Figure 1A, lane 1),
nuclear extract from cells treated with glucosamine was itself, a component of the ubiquitin-conjugation system,
or a modifier of the UPS. To simplify these studies, weinactive at Sp1 cleavage (Figure 1A, lane 2) (Su et al.,
1999). Pretreatment of the active nuclear extract with made use of synthetic fluorogenic peptides that cannot
be modified by ubiquitin or O-GlcNAc to measure thevaccinia-produced, glutathione bead-bound GST-OGT,
but not GST, GST-OGTN286, or GST-OGTN485, com- effect of OGT on the proteasome peptidases. The chy-
motrypsin-like activity was measured using the fluoro-pletely blocked the generation of SpX (Figure 1B, Sup-
plemental Figure S2 available at above URL). Only the genic peptide suc-LLVY-AMC (Figures 3A and 3B).
When this peptide was incubated with activated nuclearfull-length OGT was confirmed to be active using p62
(Han et al., 2000) as a substrate. The addition of exoge- extract, a fluorescent signal was generated (Figures 3A
and 3B). The peptidase activity of the nuclear extractnous UDP-GlcNAc was not required for the inhibition
with vaccinia-produced GST-OGT (Figure 1B, lane 3), was inhibited by multiple proteasome inhibitors, -lac-
tone, PSI, LLnL, and epoxomicin (Figure 3A), which im-but the addition of UDP-GalNAc, an inhibitor of OGT
(Haltiwanger et al., 1992), blocked the inhibitory effect plies this activity is proteasomal in origin. If the extract
was made from cells incubated with glucosamine, onlyof OGT on Sp1 cleavage (Figure 1B, lane 6). Bacterially
expressed OGT, also enzymatically active, inhibited the low fluorescence intensity was detected (Figure 3A).
When the active extract was pretreated with full-lengthcleavage of Sp1 and this effect was enhanced by the
addition of UDP-GlcNAc (Figure 1C, lane 5). The TPR GST-OGT (Figure 3B) but not GST or GST-OGTN485, the
fluorescence intensity was significantly reduced. Thedomain of OGT mediates specific protein-protein inter-
actions but, without catalytic activity, failed to inhibit inhibitory effect of OGT is as potent as the proteasome
inhibitor, epoxomicin (Figure 3B). Because the peptideSp1 cleavage (Figure 1B, lane 9; Figure 1C, lane 4).
Catalytically active His-tagged OGT (His-OGT) in this cannot be modified, the inhibition of its cleavage must
O-GlcNAc Transferase Inhibits Proteasomes
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Figure 1. Generation of GST-SpX from GST-Sp1 (degradation) by Active NE Is Inhibited by GST-OGT
(A) Recombinant GST-Sp1 is degraded by activated nuclear extract from NRK cells treated with forskolin and glucose starvation and not
degraded by extract from glucosamine-treated cells.
(B) GST-Sp1 degradation, assessed by GST Western blot, is inhibited by GST-OGT but not its truncation mutants produced by vaccinia virus.
Nucleotide-sugars (5 M) were added as indicated.
(C) GST-Sp1 degradation is inhibited by E. coli-produced GST-OGT.
(D) GST-Sp1 degradation is inhibited by His-tagged OGT produced with vaccinia virus.
result from modification by OGT of the proteasome or (Figure 4A) nor was it inhibitory for partially purified 26S
proteasomes (Figure 4B) and purified 20S proteasomesanother modifier.
(Figure 4C). These results suggest that OGT does not
inhibit global proteasomal function but modifies some26S but Not 20S Proteasomes Were Inactivated
subunit(s) to impart a differential effect on peptide sub-by OGT treatment
strate digestion.To narrow our search for the OGT substrate, we tested
if the degradation of the LLVY peptide by purified protea-
somes is inhibited by OGT. 26S proteasomes (65% The Degradation of Chymotryptic Peptide
or95% pure (HP-26S)) (Figure 3C) or 20S proteasomes Substrate Z-GGL-AMC Was Not Affected
( 95% purity) were pretreated with the beads carrying by OGT Treatment
GST alone, GST-OGT, or GST-OGTN485. Treatment of The experiments indicate that the LLVY chymotryptic
the 65% pure 26S proteasomes with the full-length GST- activity of the 26S proteasome is inhibited by OGT but
OGT beads, but not GST or GST-OGTN485, inhibited the LSTR tryptic activity is not. Furthermore, the activity
the degradation of the peptide (Figure 3D). This effect of the core particle is not modified by OGT. Since the
of catalytically active OGT required its substrate UDP- three peptidase activities of the proteasome reside in
GlcNAc (Figure 3E). However, no inhibition of the 20S the core particle, it is unlikely that the proteolytic activity
proteasome core particles was observed with OGT (Fig- of chymotryptic subunit 5 is functionally modified by
ure 3F), implying that it is not a functional target of OGT. OGT. Thus, OGT may alter the chymotrypsin-like activity
through another property of LLVY, namely its hydropho-
bicity (Figure 5A). To test this idea, another chymotrypticThe Degradation of Tryptic Peptide Substrate
Boc-LSTR-AMC Was Not Affected by OGT Treatment peptide was used as a substrate, Z-GGL-AMC. This
peptide is as hydrophilic as LSTR (Figure 5A). WhenThe observation that OGT can inhibit the degradation
of complex proteins like Sp1 and simple peptides like exposed to GST-OGT beads, cleavage of GGL by either
partially purified 26S proteasomes (Figure 5B) or activeLLVY suggests that the effect of the O-GlcNAc modifica-
tion is very general on 26S proteasome function. To nuclear extract (Figure 5C) was unaffected, while its
cleavage was blocked by epoxomicin (Figures 5B andtest this generality, the effect of OGT on the trypsin-like
activity of proteasomes was examined using a tryptic 5C), indicating that the chymotryptic cleavage of the
GGL peptide can be blocked by exogenous proteasomefluorogenic peptide substrate Boc-LSTR-AMC. Treat-
ment of nuclear extract with GST-OGT was not inhibitory inhibitors but not by OGT. These results suggest that
Cell
718
Figure 2. O-GlcNAc State of Sp1 Has No Effect on Its Proteasomal Degradation
The GST-Sp1 was analyzed by Western blot with the indicated antibodies.
(A) Anti-GST blot shows equal loading of GST-Sp1.
(B) RL-2 blot shows O-GlcNAc state of GST-Sp1.
(C) The indicated preparations of Sp1 were added to activated nuclear extract. The appearance of GST-SpX, the first step in Sp1 degradation,
was independent of the starting Sp1 O-GlcNAc level.
(D) Degradation of GST-Sp1 with different O-glycosylation levels can all be inhibited by OGT.
the chymotryptic proteolytic activity, which resides in effect on peptide substrates that correlates with the
effect of OGT on the ATPase activities of the 19S cap.the core particle of the proteasome, is not inhibited
by OGT. Rather, the inhibition is peptide specific and To determine if an independent means of inhibition of
the ATPase activity results in the same selectivity, theappears to correlate with the hydrophobicity of these
peptides. Since OGT appears to inhibit the hydrophobic activity of the proteasomal ATPases were inhibited using
a noncleavable ATP analog, AMP-PNP. The cleavage ofpeptidase activity of the 26S proteasome, then we pre-
dict that OGT modifies one or more subunits in the 19S LLVY (Figure 6A), but not that of GGL (Figure 6B) and
LSTR (Figure 6C) substrates was sensitive to AMP-PNPcap which might block access of the hydrophobic pep-
tide LLVY into the cavity of the core particle. treatment, similar to OGT pretreatment. These results
suggest that the 19S ATPases control access of hy-
drophobic but not hydrophilic peptides to the core parti-The ATPase Activity of the Proteasome Was
cle of the proteasome.Inhibited by GST-OGT
The 19S cap of the proteasome contains 6 ATPases.
To test whether OGT regulates proteasome function by Knockdown of OGT with an OGT siRNA Increases
Proteasome Function in NRK Cellsinterfering with the ATPase activity, partially purified 26S
proteasomes were exposed to GST-OGT on beads. The To determine if OGT regulates proteasome function in
vivo, we used a GFP-tagged proteasome reporter (GFP-release of inorganic phosphate from ATP was measured
before and after OGT exposure. While the proteasomes degron) (Bence et al., 2001). Cells cotransfected with
OGT siRNA, confirmed to suppress OGT expressioncontinued to release inorganic phosphate from ATP after
exposure to beads, or beads with bound GST, the beads (Supplemental Figures S3 and S4), displayed 10% stim-
ulation of GFP synthesis (Figure 6D) over cells cotrans-bearing GST-OGT markedly inhibited the ATPase activ-
ity of the 26S proteasomes (Figure 5D). To eliminate fected with a scrambled sequence. Since GFP expres-
sion is driven by the CMV promoter that contains Sp1the possibility of contamination from other more active
ATPases in the partially purified proteasomes, more binding sites, it is not unexpected that depletion of OGT
would result in less O-GlcNAc modification of Sp1 andhighly purified 26S proteasomes (Figure 3C, lane 2) were
exposed to OGT beads. OGT inhibited the LLVY cleav- therefore more Sp1 activity (Yang et al., 2001, 2002).
Nevertheless, a loss of GFP-degron fluorescence wasage by this proteasome preparation (Figure 5E). Purity
was also confirmed by measuring the relative NTPase observed in cells transfected with the OGT siRNA, re-
sulting in a net 30% loss of the GFP-degron synthesisactivity of the proteasomes before and after OGT treat-
ment. The hierarchy of Vmax was UTP, GTP, CTP, and over degradation. This observation is compatible with
the idea that only a fraction of proteasomes are inacti-ATP as previously observed (Hoffman and Rechsteiner,
1996). Again, inhibition of the ATPase activity was ob- vated by OGT in NRK cells cultured in standard medium.
The reduction of OGT would increase the degradationserved (Figure 5F), indicating that the inhibitory effect
of OGT on the ATPase activity copurified with the protea- of the reporter GFP-degron in proportion to the starting
relative number of OGT-inactivated proteasomes, in thissomes.
OGT treatment of 26S proteasomes has a differential case about 30%.
O-GlcNAc Transferase Inhibits Proteasomes
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Figure 3. The Proteasome Chymotrypsin-like Peptidase Activity Is Inhibited by OGT Plus UDP-GlcNAc
The fluorescence from the cleavage of suc-LLVY-AMC peptide was measured by fluorometry. The graphs show relative fluorescence with
100% occurring in the absence of inhibitor.
(A) Chymotrypsin-like peptidase activity in active NRK nuclear extract was inhibited by various proteasome inhibitors (50 M).
(B) Chymotrypsin-like peptidase activity in the active NE was inhibited by GST-OGT and epoxomicin but not inactive OGT truncation mutants.
(C) Commassie blue staining of SDS-PAGE 26S proteasome proteins. The proteasomes were purified to the indicated degree. The HP-26S
proteasomes were 95% pure.
(D) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes was inhibited by catalytically active GST-OGT.
(E) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes required 5 M UDP-GlcNAc for inhibition by GST-OGT.
(F) Chymotrypsin-like peptidase activity of 20S proteasome core particles was not affected by GST-OGT.
O-GlcNAcase Activates Proteasome in Inactive Subunits of the 26S Proteasome Including Rpt2
Are Modified by O-GlcNAcNRK Nuclear Extract
Treatment of NRK cells with glucose or glucosamine Evidence points to the functional substrates of OGT in
the 19S cap and the ATPases are reasonable candi-results in a nuclear extract with a significantly dimin-
ished ability to cleave LLVY (Figure 3A). To support the dates. To determine which of the subunits in the protea-
some were modified by O-GlcNAc, we treated the95%notion that OGT inhibition of this activity is catalytic,
physiological, and reversible, we determined if nuclear pure 26S proteasomes with OGT and UDP-GlcNAc. The
proteins were then resolved by two-dimensional gelextract, inactivated in vivo by culturing cells with glucos-
amine, could be reactivated by O-GlcNAcase, the en- electrophoresis and Western blotted with RL-2. While
RL-2 detected only GST-OGT (recombinant vaccinia) inzyme that specifically removes O-GlcNAc from proteins.
GST-O-GlcNAcase, expressed using vaccinia virus and the blot of OGT alone (control, data not shown), several
spots were apparent in both treated (Figure 7B) andconfirmed to be active (Roos et al., 1998), reactivated
the in vivo inactivated nuclear extract while GST did not untreated (Figure 7A) 26S proteasome samples. How-
ever, OGT treatment caused some spots to become(Figure 6E). The reactivated chymotryptic activity was
sensitive to proteasome inhibitors (Figure 6E), sug- darker. Most spots were proteasomal in origin as they
were detectable by Coomassie staining of pure protea-gesting that the enzyme was activating proteasomes in
the nuclear extract. somes run on gels (Supplemental Figure S5). At the 55
kDa, 4.8 isoelectric point coordinate, one spot (perhapsFurther substantiation of this notion was observed on
95% pure proteasomes. These proteasomes were first a doublet) changed most dramatically (arrows, Figures
7A and 7B). Its size and predicted isolectric point (http://inactivated by OGT, then treated with the O-GlcNAcase
(Figure 6F). The LLVY cleaving activity was restored to us.expasy.org/tools/pi_tool.html) correspond to Rpt2,
one of the proteasomal ATPases. The blot was stripped135% of the starting level, indicating not only that the
inhibition by OGT is reversible, but also suggesting that and reprobed with an Rpt2 antibody. The spot(s) at this
coordinate, identified by alignment markers, appearedthe purified proteasomes contained an O-GlcNAc modi-
fied inactive fraction prior to OGT treatment. The bio- as a close doublet; no other spots were detected (Figure
7C). The doublet identified as Rpt2 implies not only thatchemistry shown below furthers this point.
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To determine if Rpt2 O-GlcNAc modification occurs
in vivo under the conditions that inactivate the proteaso-
mal functions, we analyzed the O-GlcNAc state of Rpt2
in activated (forskolin) and inactivated (glucosamine)
NRK cell extract. Rpt2 was immunoprecipitated from
the cell extracts and analyzed by Western blotting with
RL-2. While Rpt2 protein quantity was similar under both
conditions (Figure 7G), the Rpt2 from the glucosamine-
treated cells showed significantly greater O-GlcNAc
modification than that from the forskolin-treated cells
(Figure 7F). Again, this modification of Rpt2 correlated
inversely with the activity of the nuclear extract to de-
grade Sp1 and the LLVY peptide.
To determine if Rpt2 is a substrate for OGT in vitro,
it was cloned and expressed as a fusion protein with
GST. Incubation of this fusion protein with OGT and
UDP-GlcNAc indicated that it was a substrate for the
enzyme (Figure 7H). Recombinant GST-Sug1 was con-
firmed not to be a substrate (Su et al., 2000) for OGT
nor was Sug2 (data not shown). The O-glycosylation
state of the other ATPases is still unclear.
Discussion
The specificity of the proteasome for substrate degrada-
tion is classically controlled by the ubiquitin system.
Under this model, the proteasome passively degrades
ubiquitin-flagged substrates that are presented to it.
Here, we describe a global control mechanism at the
level of the proteasome itself that couples intermediary
metabolism to the activity of the proteasome. Exposure
of 26S, but not 20S, proteasomes to OGT reduces the
ATPase activity of the intact proteasome, the processing
of a hydrophobic, but not hydrophilic peptides, and the
proteolysis of at least one of its protein substrates, the
transcription factor Sp1. This inhibition of proteasomal
function requires the catalytic activity of OGT. Enzymati-
cally dead truncation mutants of OGT containing the
Figure 4. The Proteasome Trypsin-like Peptidase Activity, Mea- TPR domains do not inhibit, UDP-GlcNAc is necessary
sured by Fluorescence from the Cleavage of boc-LSTR-AMC, Was
with pure proteasome preparations, and O-GlcNAcaseNot Affected by OGT Plus UDP-GlcNAc Treatment
reverses the inhibition. The modification is present on(A) Trypsin-like peptidase activity in the active nuclear extract was
untreated proteasomes and knock-down of OGT withnot affected by GST-OGT.
siRNA in intact cells results in more degradation of a(B) Trypsin-like peptidase activity of the 26S proteasomes was not
affected by GST-OGT. proteasome GFP reporter, suggesting a physiological
(C) Trypsin-like peptidase activity of the 20S proteasomes was not role for modification. However, only modification of sub-
affected by GST-OGT. units within the19S regulatory particle, which includes
the modified AAA ATPase, Rpt2, has a functional effect.
This mode of proteasomal inhibition differs from theit is modified in vitro by OGT in association with a loss
of proteasomal functions, but that it may be modified mechanism by which previously described inhibitors
block function. These proteasome inhibitors all attackin another way, giving rise to the doublet.
A one-dimensional blot also detected O-GlcNAc mod- the proteasome proteolytic subunits within the 20S core
particle. OGT, an endogenous inhibitor of proteasomes,ification of a 55 kDa protein (Figure 7D), which was
increased following exposure to OGT. The modification acts on the 19S regulatory particle, having no effect on
the 20S proteasome. Nevertheless, the action of OGTof the protein prior to recombinant OGT exposure im-
plies that the modification occurs in vivo prior to protea- may be just as global in that the ATPases of the protea-
some are vital for its function. The degradation of thesome isolation and corresponds to the idea addressed
above that proteasomes contain a mixture of inactive ubiquitinylated proteins requires the opening of the 20S
particle, probably by Rpt2 (Ko¨hler et al., 2001) and ATPO-GlcNAc and active proteasomes. This blot was
stripped and reprobed with the anti-Rpt2 serum (Figure hydrolysis to provide energy to unfold protein and trans-
locate it into 20S core particle (DeMartino and Slaughter,7E). The Rpt2 band aligned with the band detected by
RL-2. The Rpt2 antibody was cross-reactive with a bac- 1999; Rubin et al., 1998; Navon and Goldberg, 2001).
The six ATPases form a hexameric ring that abuts theterial protein in the GST and GST-OGT preparations
(Figure 7E, lanes 3 and 4). 20S core particle. These ATPase are not functionally
O-GlcNAc Transferase Inhibits Proteasomes
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Figure 5. The ATPase activity of the 26S proteasome was inhibited by OGT
(A) Average hydrophobicity score of the proteasome peptide substrates (Sweet and Eisenberg, 1983).
(B) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by 65% pure 26S proteasome was not affected by OGT
treatment.
(C) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by the active nuclear extract was not affected by OGT treatment.
(D) The ATPase activity of 65% pure 26S proteasomes was inhibited by OGT treatment.
(E) Chymotrypsin-like peptidase activity of 95% pure 26S proteasomes was inhibited by GST-OGT.
(F) The ATPase activity of 95% pure 26S proteasomes was inhibited by OGT treatment.
redundant and must act coordinately at the different et al., 1998; Hattendorf and Lindquist, 2002), at least
two of the ATPases are not substrates for OGT yet nearsteps in the degradation process (Rubin et al., 1998;
Russell et al., 2001). Since inactivation of any ATPase total loss of proteasomal ATPase function was ob-
served. Since the energy required to unfold proteinsby mutation (Rubin et al., 1998) or chemical will inhibit
proteasome function, OGT inhibition of the ATPase ac- is partially applied to the dissolution of intramolecular
hydrophobic interactions, the loss of ATPase functiontivity of the proteasome predictably inhibits the proteo-
lytic function of the entire organelle. Recently, yeast due to OGT may affect this unfolding property. Indeed,
the same peptide selectivity was observed after broadproteasomes were also shown to be metabolically re-
sponsive. In starving yeast cells, the 19S cap with its ATPase inhibition with a nonhydrolyzable ATP analog.
Taken together with the finding that Rpt2 is among theATPases dissociates from the core particle, blocking
proteasomal function to conserve the energy stored in OGT modified proteins, the data suggest that the ATPase
activity of the proteasome, and particularly that of Rpt2,synthesized proteins (Bajorek et al., 2003). Yeast cells
differ from mammalian cells in that they have no OGT is inhibited by OGT and this effect blocks the energy
exerted in the dissolution of hydrophobic protein foldingand glucose-starvation activates mammalian protea-
somes. Furthermore, OGT modification of proteasomes prior to entry into the proteasome core particle.
OGT has at least 80 substrates (Wells et al., 2003)did not result in dissociation (data not shown). Neverthe-
less, these studies further indicate the importance of making generalizations about its cellular function diffi-
cult to ascribe. Nevertheless, in certain cell types, thethe proteasomal cap, with its ATPases, in its function.
While the cleavage of the LLVY peptide was altered level of modification of several of its substrates appears
to be subject to the ambient glucose concentrationby OGT, the effect of this treatment was not observed
on another chymotryptic peptide, GGL, nor on a tryptic (Roos et al., 1998; Sayeski and Kudlow, 1996). For exam-
ple, pancreatic -cells in vivo increased O-GlcNAc con-peptide, LSTR. This observation suggests that OGT
does not alter core proteasome function at the level of tent in response to glucose (Liu et al., 2000). These cells
express a glucokinase isoform that limits the entry ofthe specific peptidases. Rather, the common feature
appears to be peptide hydrophobicity. One explanation glucose into metabolism until its concentration exceeds
5 mM (Matschinsky, 1996). The entry of glucose intofor this selectivity is that the more hydrophilic peptides
do not require the opening function of Rpt2 (Ko¨hler et muscle and adipose cells is insulin dependent, limiting
the availability of glucose to these cells during starvational., 2001) to gain access to the core particle. Another
possibility is that Rpt2 serves as a master ATPase. While when insulin levels are low. Other tissues, however, have
high affinity hexokinases and transport glucose consti-cooperation between AAA ATPase is arguable (Rubin
Cell
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Figure 6. Physiologic Role of O-GlcNAc in Proteasome Function
(A–C) AMP-PNP inhibited the degradation of LLVY (A), but not that of GGL (B) nor LSTR (C). The fluorescence signal was measured as before.
(D) Degradation versus synthesis of GFP-degron in cells cotransfected with OGT siRNA. A net increase in GFP fluorescence was observed
in cells cotransfected with OGT siRNA compared to cells cotransfected with a scrambled sequence. When GFP was tagged for proteasome
degradation, a net decrease in GFP-degron fluorescence was observed in the OGT siRNA over the scramble transfectants.
(E) The degradation of chymotryptic peptide substrate suc-LLVY-AMC by glucosamine inactivated NE was stimulated by GST-O-GlcNAcase.
Ten microliters of inactive nuclear extract was pretreated as indicated. After the GST-O-GlcNAcase on beads was removed, the supernatant
was treated with or without 50 M of the indicated proteasome inhibitor and the peptidase activity was measured.
(F) Chymotryptic activity of purified proteasomes, inhibited by OGT, can be recovered with O-GlcNAcase. The recovered activity was 35%
greater than the starting material.
Figure 7. Subunits of Pure Proteasomes In-
cluding Rpt2 Were Modified by O-GlcNAc
(A) Untreated proteasome proteins were re-
solved by two-dimensional gel electrophore-
sis and then Western blotted with RL-2. All
detectable spots are shown.
(B) Proteasomes were treated with OGT and
confirmed inactivated (LLVY assay) prior to
two-dimensional gel electrophoresis and
RL-2 blot. The filled arrow indicates the puta-
tive position of Rpt2.
(C) The blot in (B) was stripped and reprobed
with an Rpt2 antibody. Rpt2 appeared as a
close doublet (filled arrow) at the putative po-
sition while the other spots vanished (hollow
arrow). Shown here is the same area of the
gel shown in (A) and (B).
(D) Partially purified 26S proteasomes were
labeled by OGT, and the protein was resolved
by SDS-PAGE and blotted with RL-2. No pro-
teasomes were loaded on lanes 3 and 4.
(E) Anti-Rpt2 blot of the stripped membrane
from (D).
(F) Rpt2 was immunoprecipated from the cell
lysates of forskolin- or glucosamine-treated
NRK cells, and the immunoprecipitate was subjected to SDS-PAGE and Western blotting with RL-2.
(G) The Western blot, probed for Rpt2, indicates equal amounts of Rpt2 in the lysate.
(H) Recombinant GST-Rpt2 is a substrate for OGT in vitro. Recombinant Rpt2 was exposed to OGT plus UDP-GlcNAc, then analyzed by
Western blot with RL-2.
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Expression and Purification of Proteinstutively so that this metabolite is not limiting at normal
The following GST fusion proteins were expressed in E. coli or inconcentrations of glucose. In tissues that are glucose-
the vaccinia virus system (Moss, 1991; Han and Kudlow, 1997; Susensitive in these ways, this nutritional sensing mecha-
et al., 1999, 2000; Yang et al., 2002) as indicated and purified by
nism of OGT may come into play. affinity chromatography on glutathione beads: OGT, its truncation
Muscle tissue plays a dual role; one for locomotion mutants, O-GlcNAcase, Sp1, p62, hRpt2, hSug1, and hSug2. To
alter the glycosylation state of GST-Sp1, it was expressed using theand the other for energy storage. The proteasome may
vaccinia system in DMEM containing no glucose, 5mM glucose,play an important role by degrading myofibrils to provide
5 mM glucose and 5 mM streptozotocin (STZ), or 5 mM glucoseamino acids for energy (Lecker and Goldberg, 2002).
and 5 mM glucosamine.Starvation, denervation, sepsis, glucocorticoids, and
His-tagged OGT was subcloned into pcDNA3.1 and expressed
certain cytokines stimulate the UPS to degrade muscle using vTF7-3 vaccinia virus in BSC-40 cells. The protein was purified
(Wing and Goldberg, 1993) while insulin inhibits this on His-Mag agarose beads (Novagen).
p62 was cleaved off the glutathione beads with thrombin. GST-pathway (Price et al., 1996; Mitch and Goldberg, 1996).
Rpt2 was eluted with glutathione and concentrated with a MicroconThe post-absorptive insulin-stimulated flux of glucose
30 (Millipore).into skeletal muscle would provide substrate for OGT,
and the substrate-dependent O-GlcNAc inhibition of
proteasome function. The cessation of proteasome- siRNA and GST-Degron Plasmids
mediated amino acid release from muscle receiving the To generate OGT siRNA, a double-stranded oligonucleotide with
the following upper strand sequence was cloned into pSuper (Brum-insulin signal would coincide with the decreased need
melkamp et al., 2002): top strand 5-GATCCCCTGGCATCGACCTCfor the gluconeogenesis of the intact organism.
AAAGCATTCAAGAGATGCTTTGAGGTCGATGCCATTTTTGGAAA-3.The concentration of several proteins is controlled by
The bottom strand began with the sequence 5-AGCTT…. The
proteasomal degradation including oxidized and aggre- scrambled sequence with a top strand as follows was cloned into
gated proteins as well as several proapoptotic factors the same plasmid: 5-GATCCCCGACATAGCGTAAGCCTATCTTC
like p53 (Chen et al., 2000; Lopes et al., 1997) and bax AAGAGAGATAGGCTTACGCTATGTCTTTTTGGAAA-3. The GFP-
degron plasmid was constructed with the proteasome targeting(Li and Dou, 2000). Because proteasomal function can
sequence (Bence et al., 2001) between the XhoI and BhmHI sitesbe modulated by OGT, then those tissues that are glu-
of the pEGFP-C1 plasmid (Clontech, Palo Alto, CA). NRK cells werecose-sensitive may display nutritionally controlled pro-
electroporated at 250V, 500 F with 15 g of the two plasmids
teasome function which could impinge on the apoptotic (pEGFP-C1 or pEGFP-degron plus siRNA OGT or scambled in
pathways. Glucose-induced apoptosis has been ob- pSuper), then plated on a 15 cm plate for 48 hr. Fluorescence (excita-
served in pancreatic -cells of certain animal models tion 470 nm, emission 535 nm) was measured on the microfuge-
cleared cell extract (Su et al., 1999) (900 l) using a Turner Qantech(Donath et al., 1999). When the O-GlcNAcase enzyme
Digital Fluorometer (Barnstead International). The GFP (synthesis)in-cells is blocked noncompetitively by streptozotocin,
or GFP-degron (synthesis plus degradation) fluorescence of theglucose- and glucosamine-dependent apoptosis en-
OGT siRNA transfected cells was divided by the fluorescence from
sues with a failure to reverse the O-GlcNAc modification cells transfected with the plasmid containing the scrambled se-
(Liu et al., 2000). The inhibition of proteasome function quence. The assay was performed 6 times.
would also be associated with the accumulation of oxi-
dized or aggregated proteins. The relationship between
Sp1 Degradation Assaythis inhibition of proteasome function by OGT and dis-
The reconstituted Sp1 degradation assay was performed as de-
eases associated with apoptosis and the accumulation scribed (Su et al., 1999). To test the effect of OGT on the degradation
of oxidized or aggregated proteins needs further defini- of Sp1, 10 l of forskolin-activated NRK cell nuclear extract was
tion to establish causal relationships. first treated with 10 l of beads bearing GST-OGT in the presence
of 5 M UDP-GlcNAc at 22C for 30 min. After the beads were
removed, the reaction mixture was incubated at 22C for anotherExperimental Procedure
45 min after the addition of 10 ng of purified GST-Sp1. The degrada-
tion of Sp1 was monitored for the generation of GST-SpX by SDS-Materials
PAGE and Western blotting using anti-GST antibody (Su et al., 1999).The partly purified mammalian 26S proteasome fraction (estimated
purity  65%), rabbit 20S proteasome (estimated purity  95%),
and the proteasome inhibitors, Z-Ile-GLu(OtBu)-Ala-Leu-aldehyde
Proteasome Peptidase Activity Assay
(PSI) and Ac-leucine-leucine-norleucinal (LLnL) were purchased
To measure the proteasome peptidase activity in the nuclear extract,
from A.G. Scientific, San Diego, CA. The proteasome inhibitor,
100 M of one of the fluorogenic peptide substrates, suc-LLVY-
clasto-lactacystin -lactone, and substrates N-succinyl-Leu-Leu-
AMC, Boc-LSTR-AMC, or Z-GGL-AMC, was added into 10l nuclear
Val-Tyr 7-amido-4-methylcoumarin (suc-LLVY-AMC), N-T-Boc-Leu-
extract and incubated at 37C for 90 min. For the purified protea-
Ser-Thr-Arg 7-amido-4-methylcoumarin (Boc-LSTR-AMC), forskolin,
somes, 5 g of partially purified 26S, 2 g of high purity 26S, or 0.1
and UDP-[3H]GlcNAc were purchased from Sigma-Aldrich Inc, St.
g of 20S proteasome was incubated with the peptide substrate in
Louis, MO. The high purity 26S proteasome (95% pure), the sub-
proteasome activity assay buffer (50 mM Tris-HCl, [pH 7.5], 5 mM
strate, N-Benzyloxycarbonyl-Gly-Gly-L-Leu 7-amido-4-methylcou-
MgCl2, 10% glycerol, 1 mM ATP, and 1 mM DTT) in a total volumemarin (Z-GGL-AMC), and the anti-Rpt2 antibody were purchased
of 30 l at 37C for 90 min. The reactions were then stopped with
from Affinity Research Products, Exeter, UK. The EnzChek Phos-
900 l of 1% SDS. The fluorescence intensity was measured (excita-
phate Assay Kit was purchased from Molecular Probes Inc., Eu-
tion 360 nm, emission 450 nm) using a Turner Qantech Digital Fluo-
gene, OR.
rometer in triplicate. To test the effect of OGT on the proteasome
activity, the nuclear extract or purified proteasomes were first
treated with 10 l GST-OGT beads in the presence of 5 M UDP-Cell Culture and Preparation of Nuclear Extract (NE)
NRK cells were cultured in Dulbecco’s modified medium (DMEM) GlcNAc at 22C for 30 min. After the beads were centrifuged away,
the peptidase activity in the supernatant was measured as above.with 10% fetal bovine serum and BSC-40 cells were cultured in
DMEM containing 10% newborn calf serum and antibiotics. The The concentration of proteasome-specific inhibitors was 50 M
whenever they were used. The functional effectiveness of OGT onforskolin-activated and the glucosamine-inactivated NRK cell nu-
clear extracts (NE) were prepared as described (Su et al., 1999). proteasomes was pretested with suc-LLVY-AMC peptide.
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Proteasome ATPase Activity Assay cytosolic proteins: dynamic interplay between O-GlcNAc and
O-phosphate. J. Biol. Chem. 275, 29179–29182.To test the effect of OGT on the ATPase activity of proteasomes,
they were incubated with glutathione beads bearing nothing, GST, DeMartino, G.N., and Slaughter, C.A. (1999). The proteasome, a
or GST-OGT in proteasome assay buffer containing 5 M UDP- novel protease regulated by multiple mechanisms. J. Biol. Chem.
GlcNAc at 22C for 30 min. After the beads were removed, the 274, 22123–22126.
reaction mixture was then split into two parts. One part was sub- Donath, M.Y., Gross, D.J., Cerasi, E., and Kaiser, N. (1999). Hypergly-
jected to phosphate measurement immediately using the EnzChek cemia-induced -cell apoptosis in pancreatic islets of Psammomys
phosphate assay kit (Molecular Probes) as instructed. The other obesus during development of diabetes. Diabetes 48, 738–744.
part was supplemented with 300 M ATP and the further release
Gao, Y., Wells, L., Comer, F.I., Parker, G.J., and Hart, G.W. (2001).of phosphate was measured after an additional 60 min. incubation.
Dynamic O-glycosylation of nuclear and cytosolic proteins: cloningFor measurement of the Vmax NTPase activity of the proteasomes,
and characterization of a neutral, cytosolic -N-acetylglucosamini-1 mM of each of ATP, CTP, GTP, and UTP was added and phosphate
dase from human brain. J. Biol. Chem. 276, 9838–9845.generation was measured from 95% pure proteasomes treated
Glickman, M.H., and Ciechanover, A. (2002). The ubiquitin-protea-with or without OGT.
some proteolytic pathway: destruction for the sake of construction.
Physio. Rev. 82, 373–482.Identification of O-GlcNAc Modified Proteins
26S proteasomes (10 g 65% pure or 6 g  95% pure) or 0.1 g Goldberg, A.L., and Rock, K. (2002). Not just research tools—
of GST-Rpt2 recombinant protein was incubated with GST-OGT proteasome inhibitors offer therapeutic promise. Nat. Med. 8,
beads and 5 M UDP-GlcNAc in the OGT activity assay buffer (50 338–340.
mM Tris-HCl [pH 7.5], 12.5 mM MgCl2, and 1 mM DTT) at 22C for Haltiwanger, R.S., Blomberg, M.A.A., and Hart, G.W. (1992). Glyco-
90 min. The functional effectiveness of OGT to inhibit suc-LLVY- sylation of nuclear and cytoplasmic proteins: purification and char-
AMC cleavage by proteasomes was tested. After the beads were acterization of a uridine diphospho-N-acetylglucosamine:polypep-
spun down, the supernatant was resolved with SDS-PAGE or 2D tide -N-acetylglucosaminyl transferase. J. Biol. Chem. 267,
gel electrophoresis (Proteomics Laboratory, UAB) and subjected to 9005–9013.
Western blotting.
Han, I., and Kudlow, J.E. (1997). Reduced O-glycosylation of Sp1 is
associated with increased proteasome susceptibility. Mol. Cell. Biol.
Immunoprecipitation
17, 2550–2558.
After indicated treatments, 2  107 NRK cells were collected and
Han, I., Oh, E.S., and Kudlow, J.E. (2000). Responsiveness of theresuspended in 100 l denaturing lysis buffer (1% SDS, 50 mM Tris-
state of O-linked N-acetylglucosamine modification of nuclear poreHCl [pH 7.4], 5 mM EDTA, 10 mM DTT, 1 mM PMSF, and 15 u/ml
protein p62 to the extracellular glucose concentration. Biochem. J.DNAase I) and boiled for 5 min. The suspension was then diluted
350, 109–114.with 0.9 ml nondenaturing lysis buffer (1% Triton X-100, 50 mM Tris-
Hanover, J.A. (2001). Glycan-dependent signaling: O-linked N-ace-HCl [pH 7.4], 300 mM NaCl, 5 mM EDTA, 0.02% sodium azide,10
tylglucosamine. FASEB J. 15, 1865–1876.mM DTT, and 1 mM PMSF) and incubated on ice for 5 min. Rabbit
anti-Rpt2 antibody (8 l) was added to this lysate and incubated at Hanover, J.A., Lai, Z., Lee, G., Lubas, W.A., and Sato, S.M. (1999).
4C for 1 hr. The immunoprecipitate was collected on protein A Elevated O-linked N-acetylglucosamine metabolism in pancreatic
beads (Amersham) for 1 hr followed by centrifugation, washing 3 -cells. Arch. Biochem. Biophys. 362, 38–45.
times with nondenaturing buffer, and Western blotting using RL-2 Hattendorf, D.A., and Lindquist, S.L. (2002). Cooperative kinetics
antibody. of both Hsp104 ATPase domains and interdomain communication
revealed by AAA sensor-1 mutants. EMBO J. 21, 12–21.
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